Zurich Medical

What Zurich Medical does

Zurich Medical Inc. is a privately held medical device company headquartered in Minneapolis, Minnesota that develops and commercializes cardiovascular diagnostic devices. The company's flagship product is the Zurich Pressure Guidewire System Model 100, an FDA-cleared and CE-marked fractional flow reserve (FFR) measurement system used by interventional cardiologists during coronary angiography to assess the physiological significance of arterial stenoses and guide percutaneous coronary intervention (PCI) decisions. The system integrates a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor, a portable one-time-use display, a shapeable radiopaque distal tip, and an ergonomic single-button handle — marketed as the first all-in-one FFR system requiring no capital equipment purchase or maintenance.

Zurich Medical generates revenue through direct hardware sales of single-use Pressure Guidewire Systems to hospitals and cardiac catheterization labs, primarily in North America and Europe, employing a field sales motion targeting interventional cardiologists. The company holds 12 granted patents across the US, EU, China, Japan, Korea, and Australia covering its pressure guidewire technology, and supports customers with clinical education resources and US reimbursement coding guidance (CPT codes +93571, +93572, HCPCS C-Code C1769). Its core differentiator is the elimination of capital equipment costs through a disposable display architecture, positioning it as a cost-effective alternative to incumbents such as Philips and Abbott in the FFR market. The company is led by Chairman and CEO Paul J. Gam and reports a headcount of 11-50 employees.

Name

Zurich Medical

Legal name

Zurich Medical Inc.

Website

https://zurichmed.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

11–50 employees

Short description

Zurich Medical Inc. is a Minneapolis-based private medical device company that develops and sells the FDA-cleared, CE-marked Zurich Pressure Guidewire System Model 100 — a single-use, all-in-one FFR measurement device targeting interventional cardiologists and cardiac catheterization labs in North America and Europe.

Ownership category

akta.pro rank

Product category

Interventional Cardiology Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Interventional cardiology devices
• Pressure guidewire systems
• Fractional flow reserve
• Cardiovascular diagnostic devices
• Cardiac catheterization equipment

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

1. Medical Device Sales: Zurich Medical generates revenue through the sale of its Pressure Guidewire System Model 100 and related single-use components. The company sells directly to hospitals and cardiac catheterization labs, with products designed for one-time use per procedure.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Zurich Medical develops and sells the Zurich Pressure Guidewire System Model 100, an FDA-cleared and CE-marked medical device for measuring Fractional Flow Reserve (FFR) during coronary angiography. The system combines a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor and a single-use portable display, eliminating the need for hospitals to purchase capital equipment. It is sold to interventional cardiologists and cardiac catheterization labs for assessing the significance of coronary artery stenoses.

Product overview

Zurich Medical offers a single unified product — the Zurich Pressure Guidewire System Model 100™ — which is an FFR (Fractional Flow Reserve) measurement system for cardiovascular assessment. The system comprises a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor, a one-time-use portable display, and accessories including an ergonomic handle and shapeable radiopaque distal tip. This integrated medical device is designed for single-patient use, eliminating the need for healthcare facilities to purchase and maintain expensive capital equipment. The system has received both FDA 510(k) clearance and CE Mark approval for clinical use.

Differentiator

Problem solved

Functional benefit

Products and services

• Zurich Pressure Guidewire System Model 100 An FDA-cleared and CE-marked fractional flow reserve (FFR) measurement system consisting of a pressure-sensing guidewire with an advanced MEMS piezoresistive sensor and a portable one-time-use display. Measures blood pressure and flow through arterial blockages to assess the significance of coronary stenoses without requiring capital equipment. Designed for interventional cardiologists and cardiac catheterization labs performing percutaneous coronary interventions.

Quantifiable outcome

• FFR < 0.80 threshold indicates intervention required per medical guidelines
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• MedQ Consultants B.V.coreOthersEC Authorized Representative (GPG) for Zurich Medical in the European Union. Located at Baanstraat 110, 6372 AH Landgraaf, The Netherlands. Provides regulatory compliance representation for European market access.
• MedR-AR Services B.V.coreOthersEC Authorized Representative (ZMAC) for Zurich Medical in the European Union. Located at Kloosterweg 1, 6412 CN Heerlen, The Netherlands. Provides regulatory compliance representation for European market access.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Emerging players

• CathWorks: CathWorks markets the FFRangio system, performing computational FFR from standard angiograms — a wire-free alternative that could erode demand for invasive FFR guidewires like Zurich's.
• HeartFlow: HeartFlow pioneered non-invasive FFR-CT analysis — a wire-free alternative modality that competes with invasive FFR guidewires for diagnosing coronary stenosis significance.
• Medis Medical Imaging: Medis offers QFR (quantitative flow ratio), a computational FFR alternative derived from angiographic images — an emerging modality competing against traditional invasive FFR guidewires.

Broad incumbents

• GE HealthCare: GE HealthCare provides interventional cardiology imaging and integrated cath-lab systems — a broader incumbent whose cardiology franchise competes for cath-lab capital and procedural budgets.
• Siemens Healthineers: Siemens Healthineers participates in interventional cardiology imaging and integrated cath-lab solutions — a broader incumbent whose cath-lab platform competes for the same hospital budget pool as Zurich's FFR system.
• Boston Scientific: Boston Scientific markets the Comet FFR guidewire and broader interventional cardiology portfolio — a large, multi-product incumbent against which Zurich's single-product FFR offering must compete on price and workflow.
• Philips: Philips (via Volcano/PressureWire-derived assets) sells Verrata and SyncVision — a directly competitive FFR/iFR guidewire offering bundled with Philips interventional cardiology imaging and physiology systems.
• Abbott: Abbott's Vascular division sells PressureWire (certus, Aeris) — the long-standing market-leading FFR guidewire with deep clinical relationships and integrated cath-lab ecosystem, the direct incumbent Zurich competes against.

Direct peers

• Opsens: Opsens manufactures the OptoWire, an FFR guidewire using fiber-optic sensing technology — a direct technical peer in the invasive FFR guidewire category Zurich addresses.
• ACIST Medical Systems: ACIST (a Bracco subsidiary) sells the ACIST Navvus microcatheter and HemoSphere console — a directly competitive FFR measurement offering in the cath lab.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zurich-medical-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zurich Medical